Two factors immediately make Mind Medicine (NASDAQ:MNMD) stock difficult to analyze objectively.
First, MNMD stock enjoyed a massively strong session on June 7 soaring just a hair under 22%.
Second and more importantly on a personal level, I own shares of Mind Medicine. When I checked my account today, MNMD contributed very handsomely to my overall portfolio value.
So, I hope you’ll forgive me that it’s a challenge to consider the negative side of the trade. Obviously, I just want MNMD stock to keep charging higher, but this is also an incredibly dangerous time for an investor. Lulled into complacency due to prior excellent profitability, you start thinking that you have the Midas touch.
Of course, that’s when things go awry. Therefore, it’s vital to get as many perspectives as…